| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/13/2010 | US20100120121 Process for typing of HCV isolates |
| 05/13/2010 | US20100120092 Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same |
| 05/13/2010 | US20100119558 Ngna compositions and methods of use |
| 05/13/2010 | US20100119552 Purification of vaccinia viruses using hydrophobic interaction chromatography |
| 05/13/2010 | US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2010 | US20100119550 Recombinant multivalent vaccine |
| 05/13/2010 | US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines |
| 05/13/2010 | US20100119546 Vaccine against african horse sickness virus |
| 05/13/2010 | US20100119545 Modified vaccinia ankara virus variant |
| 05/12/2010 | EP2184291A1 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 05/12/2010 | EP1646715B1 Production of poxviruses with adherent or non adherent avian cell lines |
| 05/12/2010 | EP1578374B1 Escape mutants of newcastle disease virus as marker vaccines |
| 05/12/2010 | CN1829523B Viral vectors |
| 05/12/2010 | CN1810961B Recombinant influenza virus and its preparation and application |
| 05/12/2010 | CN1644686B High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 05/12/2010 | CN1617882B Method of isolation and purification of trypsin from pronase protease and use thereof |
| 05/12/2010 | CN1350578B Recombinant influenza viruses for vaccines and gene therapy |
| 05/12/2010 | CN101705246A Lentiviral gene transfer vector, preparation method and application thereof |
| 05/12/2010 | CN101191125B Chick embryo allantoic cavity inoculation method for increasing avian influenza virus separation rate |
| 05/11/2010 | US7713532 isolated hepatitis B virus (HBV) core-like particle comprising an HBV precore protein, and further not comprising HBV DNA ; vaccines; assay kit comprising an anionic surfactant and an antibody that recognizes amino acids at positions -28 to 150 of the HBV precore protein |
| 05/11/2010 | CA2527225C Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 05/11/2010 | CA2366914C Enhanced system for construction of adenovirus vectors |
| 05/11/2010 | CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 05/06/2010 | WO2010051367A1 Simian adenoviruses sadv-43, -45,-48,-49, and -50 and uses thereof |
| 05/06/2010 | WO2010050833A2 A method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages |
| 05/06/2010 | WO2010028999A3 Production of infectious hepatitis c virus particles in cell culture |
| 05/06/2010 | US20100113745 Means and Methods for Influencing the Stability of Antibody Producing Cells |
| 05/06/2010 | US20100113567 Recombinant VSV For The Treatment of Tumor Cells |
| 05/06/2010 | US20100113335 Compositions and methods for treatement of cancer |
| 05/06/2010 | US20100113300 T cell receptor display |
| 05/06/2010 | US20100112669 Mdck cells lines supporting viral growth to high titers and bioreactor process using the same |
| 05/06/2010 | US20100112668 Method For Producing Factor G Derived From HorseShoe Crab |
| 05/06/2010 | US20100112667 Microfluidic Biological Extraction Chip |
| 05/06/2010 | US20100112549 Microorganism Detection Method and Apparatus |
| 05/06/2010 | US20100112072 Controllable Virus/Protein Assemblies and Methods of Making the Same |
| 05/06/2010 | US20100112001 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| 05/06/2010 | US20100112000 Non-tumorigenic mdck cell line for propagating viruses |
| 05/06/2010 | US20100111999 Production of poxviruses with adherent or non adherent avian cell lines |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2181189A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 05/05/2010 | EP1567545B1 Peptides and their use in the treatment of central nervous system damage |
| 05/05/2010 | EP1427817B1 Multiplication of viruses in a cell culture |
| 05/05/2010 | EP0935648B1 Improved adenovirus vectors |
| 05/05/2010 | CN1500806B HIV-lgp160 membrane protein, preparing method and uses thereof |
| 05/05/2010 | CN101702918A Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment |
| 05/05/2010 | CN101702911A Imprinted polymeric materials for binding various targets such as viruses |
| 05/04/2010 | US7709621 Vectors with modified protease-dependent tropism |
| 05/04/2010 | US7709224 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 05/04/2010 | US7709007 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 04/29/2010 | WO2010048615A2 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | WO2010048572A1 A novel anti-viral method |
| 04/29/2010 | WO2010047955A2 N-linked glycosylation alteration in e0 and e2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/29/2010 | WO2010047839A1 Modified plant virus particles and uses therefor |
| 04/29/2010 | WO2010046335A1 Production of influenza virus by reverse genetics in per.c6 cells under serum free conditions |
| 04/29/2010 | WO2010046142A2 A method of obtaining high level disinfection in a washer disinfector, and a washer disinfector |
| 04/29/2010 | US20100107264 Development of influenza a antivirals |
| 04/29/2010 | US20100105124 Novel method for the production and purification of adenoviral vectors |
| 04/29/2010 | US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/29/2010 | US20100105122 Oncolytic Viruses as Phenotyping Agents for Neoplasms |
| 04/29/2010 | US20100105110 Method of Adenoviral Vector Synthesis |
| 04/29/2010 | US20100105108 Method and device for producing vaccine |
| 04/29/2010 | US20100104600 Methods and Compositions for Increasing Tissue Tropism of Recombinant Adenoviral Vectors |
| 04/29/2010 | US20100104598 Development of dengue virus vaccine components |
| 04/29/2010 | US20100104597 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | CA2741523A1 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | CA2741333A1 Vaccine against african horse sickness virus |
| 04/28/2010 | EP2180057A1 Vector system |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP1730175B1 Optimized expression of hpv 52 l1 in yeast |
| 04/28/2010 | EP1346036B1 Helper virus-free herpes virus amplicon particles and uses thereof |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | CN1820020B SARS-coronavirus virus-like particles and methods of use |
| 04/28/2010 | CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/27/2010 | US7704721 combination of high ionic strength and modest osmolarity is achieved using salts of high valency, such as sodium citrate |
| 04/27/2010 | US7704720 Propagating viral RNA sequences in host cells for use as tools in developing vaccines against viral infection; genetic vaccines; immunotherapy |
| 04/27/2010 | US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections |
| 04/27/2010 | US7704492 providing recombinant adeno-associated virus (AAV) virion which comprises an AAV vector, AAV vector comprising selected gene operably linked to control elements capable of directing in vivo transcription and translation of selected gene and introducing recombinant AAV virion into muscle cell or tissue |
| 04/27/2010 | US7704491 Recombinant human metapneumovirus and its use |
| 04/27/2010 | CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/22/2010 | WO2010044889A2 Torque teno virus (ttv) isolates and compositions |
| 04/22/2010 | WO2009158618A3 Avian reoviridae |
| 04/22/2010 | WO2009044414A1 Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy |
| 04/22/2010 | WO2008121329A3 Turkey herpesvirus vectored recombinant containing avian influenza genes |
| 04/22/2010 | US20100100978 RNAi MEDIATED EXPRESSION INHIBITION OF A CHOLINERGIC PROTEIN |
| 04/22/2010 | US20100099854 Neurovirulent strain of the west nile virus and uses thereof |
| 04/22/2010 | US20100099163 Separation matrix for viral purification |
| 04/22/2010 | US20100099162 Nuclear localization signal of lentiviral integrase and method of use thereof |
| 04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
| 04/22/2010 | US20100098725 Methods for cultivating cells, propagating and purifying viruses |
| 04/22/2010 | US20100098668 Oncolytic Adenoviruses and Uses Thereof |
| 04/22/2010 | US20100098664 Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression |
| 04/22/2010 | CA2739469A1 Torque teno virus (ttv) isolates and compositions |
| 04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
| 04/21/2010 | EP2176427A1 Avian influenza chimeric vlps |
| 04/21/2010 | EP1332217B1 Novel bacterial phytases and method for producing same |
| 04/21/2010 | EP1072010B1 Oligonucleotide mediated nucleic acid recombination |
| 04/21/2010 | CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof |
| 04/21/2010 | CN101696398A Equine infectious anemia virus pathopoiesia virulent strain ass fetus skin cell adapted strain and application |